[Osteopontin (OPN), PDGF-BB (platelet-derived growth factor) and BMP-7 (bone morphogenetic protein) as markers of atherogenesis in children with chronic kidney disease (CKD) treated conservatively--preliminary results].
D000293:Adolescent; D050197:Atherosclerosis / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism*; D000077214:Becaplermin; D015415:Biomarkers / Q000378:metabolism; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000150:complications*; D008297:Male; D053495:Osteopontin / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D020574:Proto-Oncogene Proteins c-sis; D016212:Transforming Growth Factor beta / Q000378:metabolism*
C525819:BMP7 protein, human; D015415:Biomarkers; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D016212:Transforming Growth Factor beta; D053495:Osteopontin; D000077214:Becaplermin
Osteopontyna (OPN), PDG-BB (platelet-derived growth factor) i BMP-7 (bone morphogenetic protein) jako czynniki rozwoju miazdzycy u dzieci z przewlekła choroba nerek (PChN) leczonych zachowawczo--doniesienie wstepne.